Government's Efforts To Curb Rising Cost Of Drugs

BMI View: Despite the high cost of medicines, we believe Peru's government is unlikely to abolish tax and tariff breaks for oncology, diabetes and HIV/AIDS medicines. Instead, the government is highly likely to demand that reference prices for state purchases include the discount corresponding to the value of tariff and tax exemption. There is also a possibility that the government will increase parallel imports - importing patented medicines from a country where it is legally available at a lower price - in order to curb the increasing cost of

To read the full article, please choose one of the following options: